Emergent BioSolutions Inc. (0IGA.L) Stock Price
$10.9 3.8%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
5 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Emergent BioSolutions Inc., AI stock picks, stock alerts and much more.
0IGA.L AI Stock Analysis
AI stock analysis for 0IGA.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Emergent BioSolutions Inc. (0IGA.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Emergent BioSolutions Inc. (0IGA.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Emergent BioSolutions Inc. (0IGA.L), currently trading at $10.9, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0IGA.L
-
Emergent BioSolutions Inc.
-
Symbol
0IGA.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
608.4M
Similar Stocks
 |
Waters Corporation 0LTI.L |
$411 0.3% |
5 |
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$469.9 1.5% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$150 0.3% |
8 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.5 0.4% |
3 |
 |
Walgreens Boots Alliance 0LSZ.L |
$9.75 1.2% |
4 |
News
0IGA.L Alternative Data
Web Traffic
Emergent BioSolutions Inc. receives an estimated 27097 monthly visitors to emergentbiosolutions.com.
-
Web Traffic
27097
-
Change from Previous Month
15.6%
-
3 Month Change
29.9%
News Mentions
Emergent BioSolutions Inc. was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Emergent BioSolutions Inc. has 2,710 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
2710
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
4%
Instagram Followers
Emergent BioSolutions Inc. has 954 Instagram Followers on its main Instagram account, up by 0.1% over the last month.
-
Instagram Followers
954
-
Daily Change
0.2%
-
1 Month Change
0.1%
-
3 Month Change
0%
LinkedIn Followers
43,584 are following Emergent BioSolutions Inc. on LinkedIn, up by 1.1% over the last month.
-
LinkedIn Followers
43584
-
Daily Change
0.1%
-
1 Month Change
1.1%
-
3 Month Change
2%
Job Postings
Emergent BioSolutions Inc. currenly has an estimated 17 open job postings.
-
Job Postings
17
-
Daily Change
6.3%
-
1 Month Change
0%
-
3 Month Change
26.1%
LinkedIn Employees
According to LinkedIn, Emergent BioSolutions Inc. has 1,531 employees, down by -0.9% over the last month.
-
LinkedIn Employees
1531
-
Daily Change
0.1%
-
1 Month Change
0.9%
-
3 Month Change
6%
Business Outlook
-
Business Outlook
22
-
Change from Previous Month
8.3%
-
3 Month Change
0%
-
YoY Change
0%
0IGA.L Financials
0IGA.L Key Metrics
-
Total Revenue
$269.5M
-
Net Income
$114.8M
-
Earnings per Share
$2.16
-
Free cash flow
$147.9M
-
EBITDA
$64.5M
-
EBITDA Ratio
0.239332
-
Total Assets
$1.5B
0IGA.L 2-year Revenue & Income
0IGA.L 2-year Free Cash Flow
0IGA.L Technicals
0IGA.L SMA
0IGA.L RSI
FAQ
What's the current price of Emergent BioSolutions Inc. (0IGA.L) Stock?
The price of an Emergent BioSolutions Inc. (0IGA.L) share is $10.9.
What's the market cap of Emergent BioSolutions Inc.?
The current market cap of Emergent BioSolutions Inc. is 608.4M.
Should I buy or sell 0IGA.L?
Emergent BioSolutions Inc. shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Emergent BioSolutions Inc. is better viewed as a hold or accumulate position while waiting for further developments.
Is Emergent BioSolutions Inc. a good investment?
The current analysis of Emergent BioSolutions Inc.'s fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Emergent BioSolutions Inc.'s portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Emergent BioSolutions Inc. (0IGA.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Emergent BioSolutions Inc. stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Emergent BioSolutions Inc. (0IGA.L) that investors often compare it to?
Emergent BioSolutions Inc. (0IGA.L) is often compared to similar stocks such as Waters Corporation, Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Emergent BioSolutions Inc.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Emergent BioSolutions Inc.'s stock price to be around $10.65 in 2026. Starting from the current price of $10.9, this represents a 2.3% change in price, indicating a neutral outlook for the stock.
How to buy Emergent BioSolutions Inc. (0IGA.L) Stock?
Emergent BioSolutions Inc. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Emergent BioSolutions Inc. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.